Repare Therapeutics Shareholders May be Entitled to Additional Compensation for Sale to XenoTherapeutics
ByAinvest
Friday, Nov 14, 2025 11:04 pm ET1min read
RPTX--
Halper Sadeh LLC is investigating whether the sale of Repare Therapeutics Inc. to XenoTherapeutics is fair to Repare shareholders. The proposed transaction will result in a cash payment of $1.82 per share plus contingent value rights. Halper Sadeh encourages Repare shareholders to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [info@halpersadeh.com](mailto:info@halpersadeh.com). The investigation concerns whether Repare and its board of directors violated federal securities laws and/or breached fiduciary duties.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet